Jones Soda Co. Third Quarter 2026 Earnings Call - JONES SODA CO

Explicit Guidance:

• Reaffirmed full-year 2026 revenue outlook: > $45 million (implying >80% growth vs. 2025).
• Reaffirmed full-year 2026 adjusted EBITDA: Positive.
• No formal numerical guidance provided for 2027; management expects to announce updated 2027 outlook early in 2027 after Board approval.
• Cash Flow/Working Capital: No specific targets given, but emphasis on converting inventory to sales and collecting receivables as revenue scales.

Business-Segment Outlook:

• Core Beverage: Continued expansion of Zero Sugar product line in club stores (e.g., Western Canada) and major retailers (e.g., Texas HEB); future product development will launch in tandem with "Full Sugar" and "Zero" versions to capture lapsed users.
• Consumer Lifestyle:
  • Partnerships: Pipeline of new licensing partnerships (e.g., Fallout, Crayola) expected to be announced by end of 2026 or early 2027.
  • Direct-to-Consumer (D2C): Targeting January 2027 for platform relaunch to improve user experience and introduce subscriptions; D2C revenue expected to reach ~$5 million annualized in 2026 (up from ~$1 million in 2025).
  • Product Rationalization: Discontinued Spike Jones and Pop Jones lines due to low velocity and high competition; continuing to exit underperforming SKUs.
• Functional Health and Nutrition (Jones Labs):
  • Dedicated division established; targeting Q1 2027 to begin testing new innovations.
  • Focus areas: Metabolic health, GLP-1 support (non-pharmaceutical), performance nutrition, gut health, and healthy aging.
  • Initial product pipeline includes items with clinical validation for test marketing.

Market and Competitive Outlook:

• Distribution: Continued expansion into major retailers (e.g., 250+ HEB stores in Texas); leveraging Fallout partnership to access retailers previously unavailable.
• Pricing/Margins: Targeting gross margins in the upper 30s (e.g., ~34% in Q3 2026 was a stepping stone; D2C channel expected to lift overall averages due to higher margins).
• Product Mix: Shift toward higher-margin D2C and functional health products; reducing reliance on lower-margin club channel over time as D2C scales.
• Competitive Landscape: Positioning against "me-too" products (e.g., in Pop Jones) by leveraging speed and creativity; anticipating increased interest from non-major beverage brands for strategic partnerships.

Macro / Industry Outlook:

• Market Trends: Acknowledges the broader craft soda market is generally declining; Jones aims for divergence through Zero Sugar innovation and functional health expansion.
• Consumer Behavior: Targeting consumers seeking lower sugar, metabolic health support, and performance nutrition; viewing these as enduring trends rather than fads.
• Cost Environment: Freight rates and input costs (packaging, cans, co-man) remain variables influencing quarterly margins, though volume leverage is expected to offset some costs.

Strategic Initiatives:

• D2C Platform Relaunch: Scheduled for January 2027; focuses on subscription models and enhanced user interface to drive retention.
• Jones Labs Expansion: Establishing a dedicated division for functional health; initial testing commences Q1 2027.
• IPO/Uplisting: Updated S-1 filing expected before end of 2026; targeting NYSE or NASDAQ listing in Q1 2027.
• New Partnerships: New licensing announcements expected late 2026 or early 2027; specifically referencing unresolved inquiries regarding PB&J soda reintroduction.
• ERP & Systems: Continued implementation of ERP-based requisitions, workflow automation, and standard costing to improve visibility and controls.

Risks and Headwinds to Outlook:

• Timing Variability: Margins subject to volatility from freight rates, product mix shifts, and customer shipment schedules.
• Inventory/Working Capital: Increased inventory levels (e.g., $6.5M at Q3 2026) create cash conversion risks if sales do not accelerate commensurately.
• Execution Risk: New product launches (D2C, Functional Health) depend on successful testing and consumer adoption in Q1 2027.
• Partnership Dependency: Continued success relies on the longevity of the Fallout agreement (2 years remaining) and the ability to replicate this model with new partners.
• Regulatory/SEC: Uplisting timeline contingent on SEC filing approval and Board agreements.

Management Tone on the Future:

• Confidence: Highly confident in the turnaround and the "three-pillar" strategy (Core, Lifestyle, Functional Health); describes the transition from "stabilizing" to "accelerating."
• Discipline: Repeated emphasis on capital allocation, cost control, and "disciplined processes" for evaluating opportunities.
• Caution: Explicitly avoiding 2027 financial targets until Q1; notes that "not every product will stay forever" and willingness to discontinue underperformers quickly.
• Narrative: Views 2027 as the start of the "scaling" phase with multiple growth vectors rather than a single franchise dependency.

Miscellaneous:

• Product Announcements: PB&J soda reintroduction and other "fan favorites" expected to be revealed in the first quarter of 2027.
• Geography: Zero Sugar line currently active in Western Canada club stores and Texas HEB retail.
• Financials: Q3 2026 net income $471k; Adjusted EBITDA $869k; 9-month 2026 Adjusted EBITDA $1.12M.
• Stock: No new share count or dividend guidance provided; focus on preparing for public market transition in Q1 2027.